Myelin basic protein in CSF as indicator of disease activity in multiple sclerosis

Abstract

There is an evident need for a quantitative laboratory marker for ascertaining disease activity and treatment effects in multiple sclerosis (MS) patients. Activity of the disease process in MS is accompanied by myelin breakdown and appearance of myelin basic protein (MBP) in cerebrospinal fluid (CSF). In this paper MBP in CSF of relapsing-remitting (RR) MS patients is reviewed. MBP in CSF is a fragment containing an epitope corresponding to aminoacid residues 45-89 of the native molecule. From several relevant studies about CSF MBP in RR MS the following relations can be concluded: CSF MBP levels in active MS patients are frequently increased (45-100%), remain increased until 5 to 6 weeks after onset symptoms and are higher in polysymptomatic exacerbations and correlate with number of gadolinium-enhanced (Gd) lesions on MRI, severity of relapses, EDSS score and CSF intrathecal IgM synthesis. After an intravenous methylprednisolone treatment the increased CSF MBP levels return to normal values and reduction in CSF MBP is related to reduction in EDSS score, number of Gd lesions and CSF intrathecal IgM synthesis.

Keywords

multiple sclerosis cerebrospinal fluid MBP methylprednisolone

Get full access to this article

View all access options for this article.

References

Cohen SR , Herndon RM , McKhann GM. (1976) Radio-immunoassay of myelin basic protein in spinal fluid: an index of active demyelination . N Engl J Med 295: 1455-1457 .

Whitaker JN. (1977) Myelin encephalitogenic protein fragments in cerebrospinal fluid of persons with multiple sclerosis . Neurology (Minneap) 27: 911-920 .

Thomson AY et al. (1985) CSF myelin basic protein in multiple sclerosis . Acta Neurol Scand 72: 577-583 .

Millar JHD , Vas CY , Liversedge SLA , Rawson MD. (1967) Long term treatment of multiple sclerosis with corticotrophin . Lancet 2: 429-431 .

Warren KG , Catz I. (1985) The relationshiop between levels of cerebrospinal fluid myelin basic protein and IgG measurements in patients with multiple sclerosis . Ann Neurol 17: 475-480 .

Martin-Mondiere et al. (1987) Cerebrospinal fluid myelin basic protein in multiple sclerosis . Arch Neurol 44: 276-278 .

Frequin STFM et al. (1992) Cerebrospinal fluid myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high-dose intravenous methylprednisolone . Acta Neurol Scand 86: 291-297 .

Barkhof F et al. (1992) A correlative triad of gadolinium-DTPA MRI, EDSS and CSF MBP in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone . Neurology, 42: 63-67 .

Whitaker JN et al. (1993) Correlation of myelin basic protein-like material in cerebrospinal fluid of multiple sclerosis patients with their response to glucocorticoid treatment . Ann Neurol 33: 10-17 .